CR20120566A - Tratamiento de enfermedades autoinmunes - Google Patents

Tratamiento de enfermedades autoinmunes

Info

Publication number
CR20120566A
CR20120566A CR20120566A CR20120566A CR20120566A CR 20120566 A CR20120566 A CR 20120566A CR 20120566 A CR20120566 A CR 20120566A CR 20120566 A CR20120566 A CR 20120566A CR 20120566 A CR20120566 A CR 20120566A
Authority
CR
Costa Rica
Prior art keywords
alkyl
alkoxy
halogen
treatment
autoimmune diseases
Prior art date
Application number
CR20120566A
Other languages
English (en)
Spanish (es)
Inventor
Peter Gergely
Erik Wallstroem
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42199281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20120566(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CR20120566A publication Critical patent/CR20120566A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CR20120566A 2010-05-06 2012-11-06 Tratamiento de enfermedades autoinmunes CR20120566A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10162079 2010-05-06

Publications (1)

Publication Number Publication Date
CR20120566A true CR20120566A (es) 2013-01-09

Family

ID=42199281

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120566A CR20120566A (es) 2010-05-06 2012-11-06 Tratamiento de enfermedades autoinmunes

Country Status (24)

Country Link
US (1) US20130172297A1 (enExample)
EP (1) EP2566470A1 (enExample)
JP (1) JP2013530937A (enExample)
KR (1) KR20130066630A (enExample)
CN (1) CN102869353A (enExample)
AU (1) AU2011249784B2 (enExample)
BR (1) BR112012028190A2 (enExample)
CA (1) CA2795394A1 (enExample)
CL (1) CL2012003091A1 (enExample)
CR (1) CR20120566A (enExample)
CU (1) CU20120154A7 (enExample)
EA (1) EA201201514A1 (enExample)
EC (1) ECSP12012312A (enExample)
IL (1) IL222690A0 (enExample)
MA (1) MA34285B1 (enExample)
MX (1) MX2012012926A (enExample)
NZ (1) NZ603999A (enExample)
PE (1) PE20130612A1 (enExample)
PH (1) PH12012502418A1 (enExample)
SG (1) SG185746A1 (enExample)
TN (1) TN2012000509A1 (enExample)
TW (1) TW201201814A (enExample)
WO (1) WO2011138393A1 (enExample)
ZA (1) ZA201207710B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519539B (zh) * 2010-12-21 2016-02-01 Kyorin Seiyaku Kk Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof
US9289494B2 (en) * 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE463478T1 (de) * 2001-09-27 2010-04-15 Kyorin Seiyaku Kk Diaryletherderivat, dessen additionssalz und immunosuppressivum
AU2002332289B2 (en) 2001-09-27 2007-05-10 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
AU2003264430B2 (en) 2002-09-19 2009-03-19 Kyorin Pharmaceutical Co., Ltd. Amino alcohol derivative, addition salt thereof, and immunosuppressant
DK1602660T3 (da) * 2003-02-18 2011-05-23 Kyorin Seiyaku Kk Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer
WO2004103968A1 (en) * 2003-05-26 2004-12-02 Aponetics Ag Sulfopyrroles
MXPA06002349A (es) 2003-08-28 2006-05-22 Novartis Ag Derivados de aminopropanol.
US20070167505A1 (en) * 2004-02-11 2007-07-19 Basilea Pharmaceutica Ag Substituted benzimidazoles and their use for inducing apoptosis
WO2006041015A1 (ja) * 2004-10-12 2006-04-20 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
NZ588372A (en) * 2005-09-09 2012-03-30 Novartis Ag Diphenyl ether or thioether derivatives for treatment of autoimmune diseases

Also Published As

Publication number Publication date
BR112012028190A2 (pt) 2016-08-02
AU2011249784B2 (en) 2014-03-06
TN2012000509A1 (en) 2014-04-01
US20130172297A1 (en) 2013-07-04
EP2566470A1 (en) 2013-03-13
CA2795394A1 (en) 2011-11-10
PE20130612A1 (es) 2013-06-06
JP2013530937A (ja) 2013-08-01
WO2011138393A1 (en) 2011-11-10
AU2011249784A1 (en) 2012-12-20
CN102869353A (zh) 2013-01-09
CU20120154A7 (es) 2013-03-27
KR20130066630A (ko) 2013-06-20
ECSP12012312A (es) 2012-12-28
PH12012502418A1 (en) 2018-03-21
SG185746A1 (en) 2013-01-30
MX2012012926A (es) 2012-12-17
NZ603999A (en) 2014-06-27
EA201201514A1 (ru) 2013-05-30
CL2012003091A1 (es) 2013-03-22
TW201201814A (en) 2012-01-16
MA34285B1 (fr) 2013-06-01
ZA201207710B (en) 2013-06-26
IL222690A0 (en) 2012-12-31

Similar Documents

Publication Publication Date Title
DK2185191T3 (da) Influenzavacciner med lavt indhold af tilsætningsstoffer
DK2010498T3 (da) Syntese af acylaminoalkenylenamider, der kan anvendes som substans P-antagonister
DK3502138T3 (da) Tavse Fc-varianter af anti-CD40-antistoffer
PE20131343A1 (es) Derivados de acido benzoico
UY32223A (es) Nuevos compuestos sustituidos con halogenos
DOP2009000202A (es) Compuesto anulares fusionados como agonistas parciales de ppar-gamma
EP2585437A4 (en) THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
ATE531695T1 (de) Derivate von 4-(2-amino-1-hydroxyethyl)phenol als agonisten des beta2-adrenergen rezeptors
DK2693881T3 (da) Substituerede n-phenylpyrimidin-2-amin-analoger som inhibitorer af axl-kinase
DK2534233T3 (da) Rengøringssammensætning, der omfatter amylasevarianter med høj stabilitet i nærværelse af et chelateringsmiddel
DK1885684T3 (da) Derivater af 4-(2-amoni-1-hydroxyethyl)phenol som agonister af beta-2-adrenerg receptor
DK2310382T3 (da) Amidophenoxyindazoler, der er anvendelige som hæmmere af c-met
DK2066628T3 (da) 2-Phenylindoler som antagonister af prostaglandin-D2-receptorer
IL239023A0 (en) Neutralizing antibodies to influenza viruses
DK3111764T3 (da) Tensider af amin-typen til styring af herbicid spraydrift
EA201100037A1 (ru) Органические соединения
DK2046775T3 (da) N-(amino-heteroaryl)-1h-indol-2-carboxamidderivater som, antagonister af receptorer af type trpv1 eller vr1
EP2677014A4 (en) ADHESIVE COMPOSITION
EP2445346A4 (en) OXOHETEROCYCLIC FUSIONED PYRIMIDINE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
MX343611B (es) Composicion de control de fitoenfermedades y su uso.
CO6852097A2 (es) Agentes de coalescencia amigables con el medio ambiente
EA201491153A1 (ru) КОМПОЗИЦИИ БУПРЕНОРФИНА И АНТАГОНИСТОВ μ-ОПИОИДНЫХ РЕЦЕПТОРОВ
EP2755643A4 (en) COMPOSITIONS OF JASMONATE COMPOUNDS AND APPLICATION PROCEDURES
EP2558067A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF DEHUMIDIFYING OR ELIMINATING BITTER TASTE
DK2791350T3 (da) Enzymcocktails fremstillet af blandede kulturer